UMIN ID: C000000358
Registered date:01/04/2006
A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer.
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Non small cell lung cancer |
Date of first enrollment | 2006/04/01 |
Target sample size | 25 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Chemotherapy |
Outcome(s)
Primary Outcome | Response rate |
---|---|
Secondary Outcome | adverse event, over all survival, recurrence-free survival rate, effectiveness of evaluation by PET scan |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 75years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1. active interstitial pneumonia 2. active infectious disease 3. active other cancer 4. severe drug allergy 5. severe complications |
Related Information
Primary Sponsor | Fukushima Medical University |
---|---|
Secondary Sponsor | Fukushima Red cross hospitalIwaki public hospitalSouthern Tohoku general hospitalYonezawa city hospitalSirakawa kosei hospital |
Source(s) of Monetary Support | None |
Secondary ID(s) |
Contact
public contact | |
Name | Hiroyuki Suzuki |
Address | 960-12951 Hikarigaoka Fukushima, Fukushima Japan |
Telephone | 024-547-1254 |
hiro@fmu.ac.jp | |
Affiliation | Fukushima Medical University Department of Surgery 1 |
scientific contact | |
Name | Hiroyuki Suzuki |
Address | 960-12951 Hikarigaoka Fukushima, Fukushima Japan |
Telephone | 024-547-1254 |
Affiliation | Fukushima Medical University Department of Surgery 1 |